Schneyer Mark C. (CIK 1899977) reported 27 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-07). Recent activity: Buy ACAD (5,849 shares), Sell ACAD (5,849 shares), Buy ACAD (14,292 shares), Sell ACAD (5,000 shares), Sell ACAD (9,292 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-07 | ACADIA PHARMACEUTICALS INC (ACAD) | EVP, CHIEF FINANCIAL OFFICER | Buy | 5,849 | $104,346 |
| 2026-08-07 | ACADIA PHARMACEUTICALS INC (ACAD) | EVP, CHIEF FINANCIAL OFFICER | Sell | 5,849 | $169,638 |
| 2026-08-07 | ACADIA PHARMACEUTICALS INC (ACAD) | EVP, CHIEF FINANCIAL OFFICER | Buy | 14,292 | $254,969 |
| 2026-08-07 | ACADIA PHARMACEUTICALS INC (ACAD) | EVP, CHIEF FINANCIAL OFFICER | Sell | 5,000 | $145,000 |
| 2026-08-07 | ACADIA PHARMACEUTICALS INC (ACAD) | EVP, CHIEF FINANCIAL OFFICER | Sell | 9,292 | $272,604 |
| 2026-05-05 | ACADIA PHARMACEUTICALS INC (ACAD) | EVP, CHIEF FINANCIAL OFFICER | Buy | 6,815 | $0 |
| 2026-05-05 | ACADIA PHARMACEUTICALS INC (ACAD) | EVP, CHIEF FINANCIAL OFFICER | Sell | 3,506 | $76,396 |
| 2026-04-07 | ACADIA PHARMACEUTICALS INC (ACAD) | EVP, CHIEF FINANCIAL OFFICER | Buy | 5,276 | $0 |
| 2026-04-07 | ACADIA PHARMACEUTICALS INC (ACAD) | EVP, CHIEF FINANCIAL OFFICER | Sell | 2,709 | $60,140 |
| 2026-03-26 | ACADIA PHARMACEUTICALS INC (ACAD) | EVP, CHIEF FINANCIAL OFFICER | Sell | 3,171 | $68,652 |
| 2026-03-26 | ACADIA PHARMACEUTICALS INC (ACAD) | EVP, CHIEF FINANCIAL OFFICER | Sell | 4,177 | $89,680 |
| 2026-03-26 | ACADIA PHARMACEUTICALS INC (ACAD) | EVP, CHIEF FINANCIAL OFFICER | Buy | 6,178 | $0 |
| 2026-03-26 | ACADIA PHARMACEUTICALS INC (ACAD) | EVP, CHIEF FINANCIAL OFFICER | Buy | 8,138 | $0 |
| 2026-03-26 | ACADIA PHARMACEUTICALS INC (ACAD) | EVP, CHIEF FINANCIAL OFFICER | Sell | 37 | $804 |
| 2025-11-19 | ACADIA PHARMACEUTICALS INC (ACAD) | EVP, CHIEF FINANCIAL OFFICER | Buy | 9,913 | $0 |
| 2025-11-19 | ACADIA PHARMACEUTICALS INC (ACAD) | EVP, CHIEF FINANCIAL OFFICER | Buy | 9,913 | $0 |
| 2025-11-19 | ACADIA PHARMACEUTICALS INC (ACAD) | EVP, CHIEF FINANCIAL OFFICER | Sell | 10,262 | $243,107 |
| 2025-09-16 | ACADIA PHARMACEUTICALS INC (ACAD) | EVP, CHIEF FINANCIAL OFFICER | Buy | 6,815 | $0 |
| 2025-09-16 | ACADIA PHARMACEUTICALS INC (ACAD) | EVP, CHIEF FINANCIAL OFFICER | Sell | 3,498 | $82,728 |
| 2025-08-19 | ACADIA PHARMACEUTICALS INC (ACAD) | EVP, CHIEF FINANCIAL OFFICER | Sell | 22,000 | $553,960 |
| 2025-05-19 | ACADIA PHARMACEUTICALS INC (ACAD) | EVP, CHIEF FINANCIAL OFFICER | Sell | 2,000 | $50,000 |
| 2025-05-02 | ACADIA PHARMACEUTICALS INC (ACAD) | EVP, CHIEF FINANCIAL OFFICER | Buy | 6,815 | $0 |
| 2025-05-02 | ACADIA PHARMACEUTICALS INC (ACAD) | EVP, CHIEF FINANCIAL OFFICER | Sell | 3,498 | $51,071 |
| 2025-04-08 | ACADIA PHARMACEUTICALS INC (ACAD) | EVP, CHIEF FINANCIAL OFFICER | Buy | 5,275 | $0 |
| 2025-04-08 | ACADIA PHARMACEUTICALS INC (ACAD) | EVP, CHIEF FINANCIAL OFFICER | Sell | 2,708 | $40,133 |
Source: SEC Form 4 filings · as of 2026-08-07